Vanda Pharmaceuticals Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €169.54M +3.2% -€16.12M -853.3% -9.5% -0.11 pp -€13.02M -215.8% -7.7% -0.15 pp
    €164.31M -24.3% €2.14M -60.0% 1.3% -0.012 pp €11.25M -59.6% 6.8% -0.060 pp
    €216.98M -5.3% €5.35M -81.1% 2.5% -0.099 pp €27.86M -49.6% 12.8% -0.11 pp
    €229.17M +8.3% €28.28M +42.1% 12.3% +0.029 pp €55.24M +20.9% 24.1% +0.025 pp
    €211.68M +9.2% €19.91M -79.8% 9.4% -0.41 pp €45.69M +14.1% 21.6% +0.0091 pp
    €193.78M +17.6% €98.56M +358.4% 50.9% +0.38 pp €40.06M -15.2% 20.7% -0.080 pp
    €164.72M +17.0% €21.50M -261.9% 13.1% +0.22 pp €47.21M -17,452.4% 28.7% +0.29 pp
    €140.81M +13.1% -€13.28M -13.6% -9.4% +0.029 pp -€272.09K -95.2% -0.2% +0.044 pp
    €124.55M +32.8% -€15.36M -54.8% -12.3% +0.24 pp -€5.71M -144.7% -4.6% -0.18 pp
    €93.76M +119.2% -€34.00M -297.5% -36.3% -0.77 pp €12.77M -120.6% 13.6% +1.6 pp
    €42.78M +48.0% €17.22M -199.7% 40.2% +1.0 pp -€62.08M +84.7% -145.1% -0.29 pp
    €28.90M +3.5% -€17.28M -26.8% -59.8% +0.25 pp -€33.62M -8.1% -116.3% +0.15 pp
    €27.91M +4.7% -€23.60M +182.2% -84.5% -0.53 pp -€36.59M +52.5% -131.1% -0.41 pp
    €26.67M -11.2% -€8.36M -236.3% -31.3% -0.52 pp -€24.00M +158.2% -90.0% -0.59 pp
    €30.04M +674.4% €6.13M -120.1% 20.4% +8.1 pp -€9.30M -106.0% -30.9% -40 pp
    €3.88M +∞% -€30.59M -29.8% -788.5% -7.9 pp €154.67M -502.9% 3,987.4% +40 pp
    €0.00 +NaN% -€43.56M -31.1% N/A -€38.39M -12.4% N/A
    €0.00 +NaN% -€63.18M +16.6% N/A -€43.81M +2.2% N/A
    €0.00 +NaN% -€54.17M +165.9% N/A -€42.87M +188.5% N/A
    €0.00 -100.0% -€20.37M +152.1% N/A -€14.86M +112.5% N/A
    €28.98K -€8.08M -27,881.9% -€6.99M -24,133.0%

    Notifications